The European Medicines Agency’s safety committee said on Friday Novo Nordisk’s popular weight-loss and diabetes drugs Wegovy ...

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look at the issue with Dr. Anand Parekh of the Bipartisan Policy Center.

Ozempic is a brand name for a drug known as semaglutide, which helps control blood glucose levels. Medicare Part D covers Ozempic, but the drug is not prescribed solely for weight loss. Patients using ...

Despite FDA approval of AOMs such as semaglutide and tirzepatide, coverage by Medicare and most commercial health insurance companies is limited, especially for individuals without diabetes.

Medicare and Medicaid will not cover blockbuster ... “For those who want to lose a few pounds, Ozempic and other semaglutide medications can be a big help,” he posted on Instagram in 2023.

Semaglutide was initially approved under the ... insurance doesn’t provide coverage, including Medicare and Medicaid. For some insurance policies, your health care provider needs to send in ...

"The most frustrating part is that Medicare does cover the exact same medication [semaglutide], marketed as Ozempic and approved for people with type 2 diabetes, a double standard in which one ...

Rybelsus (semaglutide) is a brand-name prescription ... If a person has an Original Medicare plan and Part D, they will pay a separate monthly premium for Part D in addition to their Part B ...

Medicare currently only covers GLP-1 drugs ... Podolsky et al, Factors Associated With Semaglutide Initiation Among Adults With Obesity, JAMA Network Open (2025). DOI: 10.1001/jamanetworkopen.

Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular semaglutide medicines as one of the 15 additional drugs covered under ...